Literature DB >> 30346918

Medical Help-Seekers with Anxiety from Deterioration in Memory are Characterized with Risk Factors for Cognitive Decline.

Ariela Gigi1, Merav Papirovitz1,2, Eli Vakil3, Therese Treves4,5.   

Abstract

Objectives: Anxiety and subjective memory complaints (SMC) are major risk factors for Mild Cognitive Impairment (MCI) and dementia. However, the association between anxiety, SMC and medical help-seeking due to complaints is not clear. Here, we assessed anxiety which rose specifically by memory examination and compared it between help-seekers in memory clinics (HS) and non-help seekers (NHS).
Methods: Twenty HS (60% female) were recruited from a memory Clinic, and 55 NHS (63% female) were recruited from the community. Participants (aged 59-82) completed objective memory assessment, Subjective Memory questionnaire, depression questionnaire and State-Trait Anxiety questionnaire. State-anxiety was assessed immediately following memory testing (indicating anxiety triggered by testing memory). For statistical evaluation, we used non-parametric tests.
Results: HS participants reported significantly higher levels of state-anxiety and had more SMC compared to the NHS. No differences in objective memory tests and trait-anxiety were found.Conclusions: People who are seeking help in memory clinics (even those who do not meet any criteria for memory decline) are liable to be at high risk for MCI and dementia.Clinical Implications: We recommend that HS with SMC should be treated as a high-risk group, even if they do not show objective memory deficits.

Entities:  

Keywords:  Dementia; medical help seeking; memory clinic; mild cognitive impairment; specific anxiety; subjective memory complaints

Mesh:

Year:  2018        PMID: 30346918     DOI: 10.1080/07317115.2018.1527423

Source DB:  PubMed          Journal:  Clin Gerontol        ISSN: 0731-7115            Impact factor:   2.619


  1 in total

1.  Why don't people with MCI approach memory clinics? The role of awareness in medical help-seeking.

Authors:  Ariela Gigi; Merav Papirovitz
Journal:  Front Neurol       Date:  2022-08-24       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.